Erratum: Risk factors for Clostridium difficile infection in the community: A case-control study in patients in general practice, Denmark, 2009-2011 (Epidemiology and Infection (2013) DOI: 10.1017/S0950268813002380);Risk factors for Clostridium difficile infection in the community: A case-control study in patients in general practice, Denmark, 2009-2011

Epidemiology and Infection

Volumn 142, Issue 7, 2014, Pages 1437-1448

  Soes, L M ^a,b   Holt, H M ^c   Bottiger B ^a,d   Nielsen, H V ^a   Andreasen, V ^b   Kemp, M ^c   Olsen, K E P ^a   Ethelberg, S ^a   Molbak, K ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b ROSKILDE UNIVERSITY   (Denmark)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antibiotics; case control study; children; community associated Clostridium difficile infection; zoonoses

Indexed keywords

DICLOXACILLIN; METRONIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN DERIVATIVE; PENICILLIN V;

ADOLESCENT; ADULT; AGED; ANIMAL COMMUNICATION; ANTIBIOTIC THERAPY; ARTICLE; BEEF; CHILD; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; DENMARK; DIARRHEA; DISEASE ASSOCIATION; DRUG USE; FEMALE; FOOD INTAKE; GASTROINTESTINAL DISEASE; GROUPS BY AGE; HOSPITALIZATION; HUMAN; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; RISK FACTOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COMMUNITY-ACQUIRED INFECTIONS; DENMARK; DRUG PRESCRIPTIONS; FEMALE; GENERAL PRACTICE; HUMANS; INFANT; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS; YOUNG ADULT;

EID: 84901634395     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268813003518     Document Type: Erratum

References (46)

1. Bartlett JG. Historical perspectives on studies of Clostridium difficile and C. difficile infection. Clinical Infectious Diseases 2008; 46: S4-S11. (Pubitemid 351323660)
2. Karlstrom O, et al. A prospective nationwide study of Clostridium difficile-associated diarrhea in Sweden. The Swedish C. difficile Study Group. Clinical Infectious Diseases 1998; 26: 141-145. (Pubitemid 28068168)
3. Noren T, et al. Molecular epidemiology of hospitalassociated and community-acquired Clostridium difficile infection in a Swedish county. Journal of Clinical Microbiology 2004; 42: 3635-3643. (Pubitemid 39045692)
4. Søes LM, et al. Clinical features of Clostridium difficile infection and molecular characterization of the isolated strains in a cohort of Danish hospitalized patients. European Journal of Clinical Microbiology and Infectious Diseases 2012; 31: 185-192.
5. Wilcox MH, et al. A case-control study of communityassociated Clostridium difficile infection. Journal of Antimicrobial Chemotherapy 2008; 62: 388-396. (Pubitemid 351984787)
6. Gould LH, Limbago B. Food Safety: Clostridium difficile in food and domestic animals: A new foodborne pathogen? Clinical Infectious Diseases 2010; 51: 577-582.
7. Keessen EC, Gaastra W, Lipman LJA. Clostridium difficile infection in humans and animals, differences and similarities. Veterinary Microbiology 2011; 153: 205-217.
8. Rodriguez-Palacios A, et al. Clostridium difficile PCR ribotypes in calves, Canada. Emerging Infectious Diseases 2006; 12: 1730-1736. (Pubitemid 44674250)
9. Rodriguez-Palacios A, et al. Clostridium difficile in retail ground meat, Canada. Emerging Infectious Diseases 2007; 13: 485-487. (Pubitemid 46348139)
10. Von Abercron SM, et al. Low occurrence of Clostridium difficile in retail ground meat in Sweden. Journal of Food Protection 2009; 72: 1732-1734.
11. Borriello SP, et al. Household pets as a potential reservoir for Clostridium difficile infection. Journal of Clinical Pathology 1983; 36: 84-87. (Pubitemid 13177657)
12. Weese JS, et al. Evaluation of Clostridium difficile in dogs and the household environment. Epidemiology and Infection 2010; 138: 1100-1104.
13. Yearsley KA, et al. Proton pump inhibitor therapy is a risk factor for Clostridium difficile-associated diarrhoea. Alimentary Pharmacology & Therapeutics 2006; 24: 613-619. (Pubitemid 44127842)
14. Kuntz J, et al. Incidence of and Risk Factors for Community-associated Clostridium difficile Infection: A nested case-control study. BMC Infectious Diseases 2011; 11: 194.
15. Dial S, et al. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficileassociated disease. Journal of American Medical Association 2005; 294: 2989-2995. (Pubitemid 41817660)
16. Hensgens MPM, et al. Clostridium difficile infection in an endemic setting in the Netherlands. European Journal of Clinical Microbiology and Infectious Diseases 2011; 30: 587-593.
17. Naggie S, et al. A Case-control Study of Communityassociated Clostridium difficile Infection: No Role for Proton Pump Inhibitors. American Journal of Medicine 2011; 124: 276.
18. Bavishi C, DuPont HL. Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection. Alimentary Pharmacology & Therapeutics 2011; 34: 1269-1281.
19. Pépin J, Gonzales M, Valiquette L. Risk of secondary cases of Clostridium difficile infection among household contacts of index cases. Journal of Infection 2012; 64: 387-390.
20. Blom M, et al. Evaluation of Statens Serum Institut enteric medium for detection of enteric pathogens. Journal of Clinical Microbiology 1999; 37: 2312-2316. (Pubitemid 29277797)
21. Hutchinson DN, Bolton FJ. Improved blood free selective medium for the isolation of Campylobacter jejuni from faecal specimens. Journal of Clinical Pathology 1984; 37: 956-957.
22. Persson S, et al. A method for fast and simple detection of major diarrhoeagenic Escherichia coli in the routine diagnostic laboratory. Clinical Microbiology and Infection 2007; 13: 516-524. (Pubitemid 46563502)
23. Kageyama T, et al. Broadly reactive and highly sensitive assay for Norwalk-like viruses based on real-time quantitative reverse transcription-PCR. Journal of Clinical Microbiology 2003; 41: 1548-1557. (Pubitemid 36428103)
24. Johnsen CK, Midgley S, Böttiger B. Genetic diversity of sapovirus infections in Danish children 2005-2007. Journal of Clinical Virology 2009; 46: 265-269.
25. Pang XL, et al. Increased detection of rotavirus using a real time reverse transcription-polymerase chain reaction (RT-PCR) assay in stool specimens from children with diarrhea. Journal of Medical Virology 2004; 72: 496-501. (Pubitemid 38133992)
26. Logan C, O'Leary JJ, O'Sullivan N. Real-time reverse transcription-PCR for detection of rotavirus and adenovirus as causative agents of acute viral gastroenteritis in children. Journal of Clinical Microbiology 2006; 44: 3189-3195. (Pubitemid 44413750)
27. Logan C, O'Leary JJ, O'Sullivan N. Real-time reverse transcription PCR detection of norovirus, sapovirus and astrovirus as causative agents of acute viral gastroenteritis. Journal of Virological Methods 2007; 146: 36-44. (Pubitemid 350030936)
28. Stensvold CR, Nielsen HV. Comparison of microscopy and PCR for detection of intestinal parasites in Danish patients supports an incentive for molecular screening platforms. Journal of Clinical Microbiology 2012; 50: 540-541.
29. Persson S, Torpdahl M, Olsen KE. New multiplex PCR method for the detection of Clostridium difficile toxin A (tcdA) and toxin B (tcdB) and the binary toxin (cdtA/cdtB) genes applied to a Danish strain collection. Clinical Microbiology and Infection 2008; 14: 1057-1064. (Pubitemid 352748847)
30. O'Neill GL, et al. Modification of a PCR Ribotyping Method for Application as a Routine Typing Scheme for Clostridium difficile. Anaerobe 1996; 2: 205-209. (Pubitemid 26336409)
31. Stubbs SL, et al. PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. Journal of Clinical Microbiology 1999; 37: 461-463. (Pubitemid 29056430)
32. Kuijper EJ, Coignard B, Tull P. Emergence of Clostridium difficile-associated disease in North America and Europe. Clinical Microbiology and Infection 2006; 12 (Suppl. 6): 2-18. (Pubitemid 44362038)
33. McDonald LC, et al. Recommendations for surveillance of Clostridium difficile-associated disease. Infection Control and Hospital Epidemiology 2007; 28: 140-145. (Pubitemid 46374153)
34. Dial S, et al. Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection. Canadian Medical Association Journal 2008; 179: 767-772.
35. Kelly CP. A 76-year-old man with recurrent Clostridium difficile-associated diarrhea: review of C. difficile infection. Journal of American Medical Association 2009; 301: 954-962.
36. Kutty PK, et al. Risk factors for and estimated incidence of community-associated Clostridium difficile infection, North Carolina, USA. Emerging Infectious Diseases 2010; 16: 197-204.
37. Holst E, Helin I, Mardh PA. Recovery of Clostridium difficile from children. Scandinavian Journal of Infectious Diseases 1981; 13: 41-45. (Pubitemid 11136514)
38. Vesikari T, et al. Clostridium difficile in young children. Association with antibiotic usage. Acta Paediatrica Scandinavica 1984; 73: 86-91. (Pubitemid 14177210)
39. Viscidi R, Willey S, Bartlett JG. Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations. Gastroenterology 1981; 81: 5-9. (Pubitemid 11078473)
40. Kim J, et al. Epidemiological features of Clostridium difficile-associated disease among inpatients at children's hospitals in the United States, 2001-2006. Pediatrics 2008; 122: 1266-1270.
41. Zilberberg MD, Tillotson GS, McDonald C. Clostridium difficile infections among hospitalized children, United States, 1997-2006. Emerging Infectious Diseases 2010; 16: 604-609.
42. Turco R, et al. Proton pump inhibitors as a risk factor for paediatric Clostridium difficile infection. Alimentary Pharmacology and Therapeutics 2010; 31: 754-759.
43. Damborg P, et al. Occurrence of Campylobacter jejuni in pets living with human patients infected with C. jejuni. Journal of Clinical Microbiology 2004; 42: 1363-1364. (Pubitemid 38332891)
44. Rupnik M. Clostridium difficile: (re)emergence of zoonotic potential. Clinical Infectious Diseases 2010; 51: 583-584.
45. Keel K, et al. Prevalence of PCR ribotypes among Clostridium difficile isolates from pigs, calves, and other species. Journal of Clinical Microbiology 2007; 45: 1963-1964. (Pubitemid 46933933)
46. Goorhuis A, et al. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clinical Infectious Diseases 2008; 47: 1162-1170.